With the aim of identifying innovative therapeutic strategies for osteosarc
oma patients who are refractory to conventional chemotherapy, we analyzed t
he in vitro effects of the blockage of autocrine circuits. Since the insuli
n-like growth factor-I receptor (IGF-IR)-mediated loop is relevant to the g
rowth of osteosarcoma, we analyzed the activity of the ICF-IR-blocking anti
body alpha IR3 in both sensitive and multidrug-resistant osteosarcoma cell
lines. Only limited effects, however, were observed, suggesting the simulta
neous existence of other autocrine circuits. Indeed, in a representative pa
nel of 12 human osteosarcoma cell lines, in addition to the IGF-IR-mediated
circuit, we demonstrated also a loop mediated by epidermal growth factor r
eceptor as well as the presence of nerve growth factor, low-affinity nerve
growth factor receptor as well as tyrosine receptor kinase A in the great m
ajority of osteosarcomas. Therapies based on the inhibition of single circu
its may have only limited effects in osteosarcoma, whereas the use of suram
in, a drug which, besides other activities, non-selectively interferes with
the binding of growth factors to their receptors, appears as a promising a
lternative, in both sensitive and drug-resistant osteosarcoma cells. (C) 19
99 WiIey-Liss, Inc.